Search clinical trials for: Trendelenburg angle

Total 1759 results

Allergan

Terminated

A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma

China
Ohio State University Comprehensive Cancer Center

Withdrawn

Steep Trendelenburg Positioning on Intra-Ocular Pressure During Surgery for Endometrial Robotics Versus Laparotomy

Intraocular Pressure
Instituto de Oftalmología Fundación Conde de Valenciana

Completed

Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies (ALPIECA)

Glaucoma | Angle Closure Glaucoma

Mexico
Alcon Research

Completed

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma

United States
Allergan

Completed

A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension (APOTUS)

Ocular Hypertension | Glaucoma, Open-Angle

China
Allergan

Completed

A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension (LOTUSDI)

Ocular Hypertension | Glaucoma, Open-Angle

China
Alcon Research

Completed

Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma
William Beaumont Hospitals

Terminated

A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients

Intraocular Pressure Disorder

United States
Alcon Research

Completed

A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Alcon Research

Completed

Safety and Efficacy of Travoprost/Timolol BAC-free

Ocular Hypertension | Open-Angle Glaucoma

Japan
Alcon Research

Completed

Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Alcon Research

Completed

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

Ocular Hypertension | Open Angle Glaucoma
Alcon Research

Completed

Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-angle Glaucoma
Alcon Research

Completed

Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada

Ocular Hypertension | Glaucoma | Open-angle Glaucoma
University of Leicester

Unknown

Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery

Colorectal Cancer

United Kingdom
Mashhad University of Medical Sciences

Completed

Clinical Trial on Frozen Shoulder Using Bilateral Shoulder Radiography in Different Position

Frozen Shoulder

Iran, Islamic Republic of
Boehringer Ingelheim

Completed

TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in Belgium

Hypertension

Belgium
University of Michigan
GE Healthcare

Completed

Cobb Angle Measurement of Kyphosis and Scoliosis

Scoliosis | Kyphosis
Allergan

Completed

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Germany, Netherlands
Alcon Research

Completed

Efficacy of Changing to TRAVATAN® From Prior Therapy

Ocular Hypertension | Open-angle Glaucoma
Allergan

Completed

A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

Austria
Yonsei University

Completed

Comparison of Different Inspiratory to Expiratory Ratios on Respiratory Mechanics and Oxygenation in Robot-assisted Laparoscopic Radical Prostatectomy With Steep Trendelenburg Position and Pneumoperitoneum

General Anesthesia Using Endotracheal Intubation

Korea, Republic of
Chuncheon Sacred Heart Hospital

Unknown

Risk Factors for Recurrence of Primary Bile Duct Stones

Common Bile Duct Stones

Korea, Republic of
Alcon Research

Completed

Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy

Ocular Hypertension | Glaucoma
Alcon Research

Completed

Efficacy of Changing to TRAVATAN® From Prior Therapy

Ocular Hypertension | Open-Angle Glaucoma
Sensimed AG

Withdrawn

IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy

Primary Open Angle Glaucoma

France
Sensimed AG

Withdrawn

IOP Pattern in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After LPI

Glaucoma

France
Aristotle University Of Thessaloniki

Completed

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Primary Open Angle Glaucoma | Ocular Hypertension

Greece
Aristotle University Of Thessaloniki

Completed

24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination

Primary Open Angle Glaucoma | Exfoliation Syndrome

Greece
Aristotle University Of Thessaloniki

Completed

24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination

Glaucoma

Greece
Genzyme, a Sanofi Company
BioMarin/Genzyme LLC

Completed

A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients

Mucopolysaccharidosis I | Hurler's Syndrome | Hurler-Scheie Syndrome | Scheie's Syndrome

United States
National University Hospital, Singapore

Completed

Prospective Evaluation of the Efficacy of Pascal Laser Iridotomy and Pascal Laser Peripheral Iridoplasty: A Pilot Study

Glaucoma

Singapore
Aerie Pharmaceuticals

Completed

24-hour Efficacy of AR-12286

Ocular Hypertension | Open Angle Glaucoma

United States
Damascus University

Completed

Mechanism of Class II Correction With Fixed Lingual Mandibular Growth Modificator (FLMGM) (FLMGM)

Class II Division 1 Malocclusion

Syrian Arab Republic
Tibotec Pharmaceuticals, Ireland

Approved for marketing

TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.

HIV Infections

United States, Belgium, Germany, Taiwan, Spain, Switzerland, Mexico, Slovenia, Malaysia, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary, Luxembourg, Venezuela
Alcon Research

Completed

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Federal University of São Paulo

Unknown

Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma

Pediatric Glaucoma

Brazil
Alcon Research

Completed

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Allergan

Completed

Safety and Efficacy of Combigan® Ophthalmic Solution in Korea

Ocular Hypertension | Glaucoma, Open-Angle

Korea, Republic of
Corporacion Parc Tauli

Unknown

Inadequate Emergence After Laparoscopic Surgery in Trendelemburg Position

Confusion | Delayed Emergence From Anesthesia | Delirium, Cause Unknown | Disorientation on Emergence

Spain
Allergan

Completed

Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

Switzerland
Assiut University

Completed

rTMS as a Treatment of Visceral Pain Secondary to Malignancy

Malignancy
Aerie Pharmaceuticals

Completed

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Ocular Hypertension | Open Angle Glaucoma

United States
Kubota Vision Inc.
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Primary Open-angle Glaucoma

United States
Glaukos Corporation

Completed

Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract

Open-angle Glaucoma
Alcon Research

Completed

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
Xiaodong Zhou

Completed

Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients

Primary Open-angle Glaucoma
Assiut University

Completed

rTMS as a Treatment of Neuropathic Pain Secondary to Malignancy

Malignancy
Alcon Research

Completed

Patient Preference Comparison of AZARGA Versus COSOPT

Ocular Hypertension | Open-Angle Glaucoma
Alcon Research

Completed

Efficacy of Changing to DUOTRAV® From Prior Therapy

Ocular Hypertension | Open-Angle Glaucoma | Pigment Dispersion Glaucoma

3

Subscribe